TrialHealth and quality of life outcomes2017

Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies.

Shuichi Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.